Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.86

+1.3%

Dec 24 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2187)	2/25/2008 11:37:21 AM
From: Jibacoa	Read Replies (2) of 3722

IDEV has been up 11.43% & still is up 9.30% with volume of 753,248 just getting ahead of its ADV. bigcharts.marketwatch.com It announced earlier this month that it was advised by the United Kingdom's MMRC that after review of data from the PIII of PRO 2000 it recommended that the low-dose arm continue to be tested for safety and effectiveness & the high-dose arm be closed. MDP 301 is a multi-national, randomized, double-blind, placebo-controlled PIII trial designed to examine the safety and effectiveness of PRO 2000 in preventing HIV infection in women. Approximately 7,730 women have been enrolled in the trial so far & completion is expected in late 2009. As previously mentioned, the stock needs to close above $7.35 in order to get off from the DT coming from its Oct17 H at $8.22 & it has now resistance at the $6 level since my previous posting. <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next